Validea’s guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY) shows it rates highest with the P/B Growth Investor model. The stock is a large-cap growth stock in the Biotechnology & Drugs industry, with a strategy rating of 66%. The stock passes most criteria in the model, indicating strong interest. Partha Mohanram’s growth model looks for low book-to-market stocks with sustained future growth potential. Mohanram, a professor at the University of Toronto, developed a growth model that has produced significant market outperformance. Validea is an investment research service that follows the strategies of investment legends like Warren Buffett and Peter Lynch.

Read more at Nasdaq: ALNY Quantitative Stock Analysis | Nasdaq